CA3075331A1 - Nouvelles compositions destinees au traitement de la sclerose laterale amyotrophique - Google Patents

Nouvelles compositions destinees au traitement de la sclerose laterale amyotrophique Download PDF

Info

Publication number
CA3075331A1
CA3075331A1 CA3075331A CA3075331A CA3075331A1 CA 3075331 A1 CA3075331 A1 CA 3075331A1 CA 3075331 A CA3075331 A CA 3075331A CA 3075331 A CA3075331 A CA 3075331A CA 3075331 A1 CA3075331 A1 CA 3075331A1
Authority
CA
Canada
Prior art keywords
combination
drug
baclofen
als
cinacalcet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3075331A
Other languages
English (en)
Inventor
Daniel Cohen
Serguei Nabirochkin
Ilya Chumakov
Rodolphe HAJJ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharnext SA
Original Assignee
Pharnext SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/053570 external-priority patent/WO2012117076A2/fr
Priority claimed from PCT/EP2012/053565 external-priority patent/WO2012117073A2/fr
Application filed by Pharnext SA filed Critical Pharnext SA
Publication of CA3075331A1 publication Critical patent/CA3075331A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA3075331A 2012-03-01 2013-02-28 Nouvelles compositions destinees au traitement de la sclerose laterale amyotrophique Abandoned CA3075331A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EPPCT/EP2012/053570 2012-03-01
PCT/EP2012/053570 WO2012117076A2 (fr) 2011-03-01 2012-03-01 Thérapie de troubles neurologiques à base de baclofène et d'acamprosate
PCT/EP2012/053565 WO2012117073A2 (fr) 2011-03-01 2012-03-01 Nouvelles compositions destinées au traitement de troubles neurologiques
EPPCT/EP2012/053565 2012-03-01
CA2864008A CA2864008C (fr) 2012-03-01 2013-02-28 Nouvelles compositions destinees au traitement de la sclerose laterale amyotrophique

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2864008A Division CA2864008C (fr) 2012-03-01 2013-02-28 Nouvelles compositions destinees au traitement de la sclerose laterale amyotrophique

Publications (1)

Publication Number Publication Date
CA3075331A1 true CA3075331A1 (fr) 2013-09-06

Family

ID=51619337

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2864008A Active CA2864008C (fr) 2012-03-01 2013-02-28 Nouvelles compositions destinees au traitement de la sclerose laterale amyotrophique
CA3075331A Abandoned CA3075331A1 (fr) 2012-03-01 2013-02-28 Nouvelles compositions destinees au traitement de la sclerose laterale amyotrophique

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2864008A Active CA2864008C (fr) 2012-03-01 2013-02-28 Nouvelles compositions destinees au traitement de la sclerose laterale amyotrophique

Country Status (2)

Country Link
CA (2) CA2864008C (fr)
IN (1) IN2014DN07989A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016081472A1 (fr) 2014-11-21 2016-05-26 Biohaven Pharmaceutical Holding Company Ltd. Formulation sublinguale de riluzole
AU2015350142A1 (en) * 2014-11-21 2017-06-15 Biohaven Pharmaceutical Holding Company Ltd. Sublingual administration of riluzole

Also Published As

Publication number Publication date
CA2864008C (fr) 2020-04-21
IN2014DN07989A (fr) 2015-05-01
CA2864008A1 (fr) 2013-09-06

Similar Documents

Publication Publication Date Title
US10682342B2 (en) Compositions for treating amyotrophic lateral sclerosis
DK2819664T3 (en) NEW COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
JP6416328B2 (ja) 筋萎縮性側索硬化症の治療のための新規組成物
AU2018201436B2 (en) New therapeutic approaches for treating Parkinson's disease
US10342768B2 (en) Therapeutic approaches for treating Parkinson's disease
US10010515B2 (en) Therapeutic approaches for treating Parkinson's disease
CA2864008C (fr) Nouvelles compositions destinees au traitement de la sclerose laterale amyotrophique
EP2819664B1 (fr) Nouvelles compositions pour le traitement de la sclérose latérale amyotrophique
AU2018201400B2 (en) New compositions for treating amyotrophic lateral sclerosis
AU2013291970A1 (en) Baclofen and acamprosate based therapy of Macular Degeneration disorders
CN104487064B (zh) 用于治疗肌萎缩性侧索硬化症的新组合物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20200311

FZDE Discontinued

Effective date: 20220809

FZDE Discontinued

Effective date: 20220809